AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasim-Karakas, S. E
Right arrow Articles by Lasley, B. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasim-Karakas, S. E
Right arrow Articles by Lasley, B. L
Agricola
Right arrow Articles by Kasim-Karakas, S. E
Right arrow Articles by Lasley, B. L
American Journal of Clinical Nutrition, Vol. 76, No. 6, 1422-1427, December 2002
© 2002 American Society for Clinical Nutrition


Original Research Communication

Effects of prune consumption on the ratio of 2-hydroxyestrone to 16{alpha}-hydroxyestrone1,2,3

Sidika E Kasim-Karakas, Rogelio U Almario, Laura Gregory, Heather Todd, Rodney Wong and Bill L Lasley

1 From the Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine (SEK-K, RUA, and LG), the Institute of Toxicology and Environmental Health (HT and BLL), and the Department of Statistics (RW), University of California, Davis.

Background: A higher urinary ratio of the biologically inactive estrogen metabolite, 2-hydroxyestrone (2OHE1), to the biologically active metabolite, 16{alpha}-hydroxyestrone (16{alpha}OHE1), may be associated with a lower risk of breast cancer. High fiber intake is also associated with decreased breast cancer risk.

Objective: We investigated the effects of prunes, which are naturally rich in both soluble and insoluble fiber, on the concentrations of 2OHE1 and 16{alpha}OHE1 and on the ratio of 2OHE1 to 16{alpha}OHE1.

Design: Nineteen healthy premenopausal women consumed their habitual diets for 3 menstrual cycles and then consumed 100 g prunes/d for the next 3 cycles. Concentrations of urinary 2OHE1 and 16{alpha}OHE1 were determined during the follicular and luteal phases.

Results: Prune supplementation increased total and soluble fiber intakes by 4 and 2 g/d, respectively (P < 0.001). Mean (± SEM) luteal 2OHE1 excretion decreased from 3.92 ± 0.79 to 2.20 ± 0.40 nmol/mmol creatinine during the third cycle (P = 0.017). Luteal 16{alpha}OHE1 excretion decreased from 1.38 ± 0.24 to 0.87 ± 0.10 and 0.87 ± 0.15 nmol/mmol creatinine during the first and third cycles, respectively (P = 0.018 for both values). Follicular 16{alpha}OHE1 excretion decreased significantly only during the first cycle (from 0.82 ± 0.12 to 0.45 ± 0.09 nmol/mmol creatinine; P = 0.005). The 2OHE1-16{alpha}OHE1 ratio did not change significantly after prune supplementation.

Conclusions: Prune supplementation significantly decreased the excretion of 16{alpha}OHE1 during the follicular phase of the first menstrual cycle and during the luteal phases of both the first and third menstrual cycles. The 2OHE1-16{alpha}OHE1 ratio did not change significantly. The potential significance of the decrease in 16{alpha}OHE1 excretion, without a change in the 2OHE1-16{alpha}OHE1 ratio, on the prevention of estrogen-dependent cancers remains to be determined.




This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
W.-H. Wu, L.-Y. Liu, C.-J. Chung, H.-J. Jou, and T.-A. Wang
Estrogenic Effect of Yam Ingestion in Healthy Postmenopausal Women
J. Am. Coll. Nutr., August 1, 2005; 24(4): 235 - 243.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Kasim-Karakas, R. U. Almario, L. Gregory, R. Wong, H. Todd, and B. L. Lasley
Metabolic and Endocrine Effects of a Polyunsaturated Fatty Acid-Rich Diet in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 615 - 620.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition